Evidence for a new mechanism behind HIFU-triggered release from liposomes

被引:59
作者
Oerlemans, Chris [1 ,2 ]
Deckers, Roel [2 ]
Storm, Gert [3 ]
Hennink, Wim E. [3 ]
Nijsen, J. Frank W. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands
[2] UniMed Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands
关键词
High-intensity focused ultrasound (HIFU); Thermosensitive liposomes; Nanoparticles; Triggered release; Drug delivery systems (DDS); Controlled release; TEMPERATURE-SENSITIVE LIPOSOMES; INTENSITY FOCUSED ULTRASOUND; CONTROLLED DRUG-DELIVERY; RADIATION FORCE; CHOLESTEROL INCORPORATION; SOLID TUMORS; IN-VIVO; PACLITAXEL; CANCER; PERMEABILITY;
D O I
10.1016/j.jconrel.2013.03.019
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A promising approach for local drug delivery is high-intensity focused ultrasound (HIFU)-triggered release of drugs from stimuli-responsive nanoparticles such as liposomes. The aim of this study was to investigate whether another release mechanism is involved with HIFU-triggered release from liposomes beside cavitation and temperature. Furthermore, it was studied whether this new release mechanism allows the release of lipophilic compounds. Therefore, both a lipophilic (Nile red) and a hydrophilic (fluorescein) compound were loaded into thermosensitive (TSL) or non-thermosensitive liposomes (NTSL) and the liposomes were subjected both to continuous wave (CW)- and pulsed wave (PW)-HIFU. The mean liposome size varied from 97 to 139 nm with a polydispersity index (PDI) <= 0.06 for the different formulations. The T-m of the phospholipid bilayer of the TSL was around 42 degrees C. Approximately 80% of fluorescein was released within 15 min from TSL at temperatures >= 42 degrees C. In contrast, no fluorescein release from NTSL and NR release from both TSL and NTSL was observed at temperatures up to 60 degrees C. CW-HIFU exposure of TSL resulted in rapid temperature elevation up to 52 degrees C and subsequently almost quantitative fluorescein release. Fluorescein release from NTSL was also substantial (similar to 64% after 16 min at 20 W). Surprisingly, CW-HIFU exposure (20 W for 16 min) resulted in the release of NR from TSL (similar to 66% of the loaded amount), and this was even higher from NTSL (similar to 78%). PW-HIFU exposure did not result in temperatures above the T-m of TSL. However, nearly 85% of fluorescein was released from TSL after 32 min at 20 W of PW-HIFU exposure, whereas the release from NTSL was around 27%. Interestingly, NR release from NTSL was similar to 30% after 2 min PW-HIFU exposure and increased to similar to 70% after 32 min. Furthermore, addition of microbubbles to the liposomes prior to PW-HIFU exposure did not result in more release, which suggests that cavitation can be excluded as the main mechanism responsible for the triggered release of both a hydrophilic and a lipophilic model compound from liposomes. Dynamic light scattering analysis showed that the mean size and PDI of the liposomes did not significantly change after CW- and PW-HIFU exposure. Taken together, it is therefore concluded that neither temperature elevation nor inertial cavitation is essential for the release of both hydrophilic and lipophilic compounds from liposomes. It is assumed that the release originates from radiation force-induced acoustic streaming, causing the liposomes to collide at the walls of the exposure chamber leading to shear forces which in turn results in reversible liposome destabilization and release of both hydrophilic and lipophilic compounds. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 57 条
[1]   Bio-effects and safety of low-intensity, low-frequency ultrasonic exposure [J].
Ahmadi, Farzaneh ;
McLoughlin, Ian V. ;
Chauhan, Sunita ;
ter-Haar, Gail .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2012, 108 (03) :119-138
[2]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[3]  
APFEL RE, 1982, BRIT J CANCER, V45, P140
[4]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134
[5]   Thermo-responsive systems for controlled drug delivery [J].
Bikram, Malavosklish ;
West, Jennifer L. .
EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (10) :1077-1091
[6]   Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes [J].
Campbell, RB ;
Balasubramanian, SV ;
Straubinger, RM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (08) :1091-1105
[7]   Mechanical bioeffects of ultrasound [J].
Dalecki, D .
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, 2004, 6 :229-248
[8]   Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance [J].
de Smet, Mariska ;
Langereis, Sander ;
van den Bosch, Sandra ;
Grull, Holger .
JOURNAL OF CONTROLLED RELEASE, 2010, 143 (01) :120-127
[9]   Ultrasound triggered, image guided, local drug delivery [J].
Deckers, Roel ;
Moonen, Chrit T. W. .
JOURNAL OF CONTROLLED RELEASE, 2010, 148 (01) :25-33
[10]   Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate [J].
Djanashvili, Kristina ;
ten Hagen, Timo L. M. ;
Blange, Roy ;
Schipper, Debby ;
Peters, Joop A. ;
Koning, Gerben A. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (03) :1123-1130